AMOXICILINA/ACID CLAVULANIC KRKA 400 mg/57 mg/5 ml Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

amoxicilina/acid clavulanic krka 400 mg/57 mg/5 ml

krka, d.d., novo mesto - slovenia - kalii + acid clavulanicum - pulb. pt. susp. orala - 400mg/57mg/5ml - antibiotice beta-lactamice, peniciline peniciline in combinatii incl. inhibitori de betalactamaza

PRENESSA 4 mg Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

prenessa 4 mg

krka, d.d., novo mesto - slovenia - perindoprilum - compr. orodispersabile - 4mg - inhibitori ai enzimei de conversie a angiotensinei inhibitori ai enzimei de conversie a angiotensinei

PRENESSA 8 mg Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

prenessa 8 mg

krka, d.d., novo mesto - slovenia - perindoprilum - compr. orodispersabile - 8mg - inhibitori ai enzimei de conversie a angiotensinei inhibitori ai enzimei de conversie a angiotensinei

DONASERTONE 20 micrograme/24 ore Румъния - румънски - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

donasertone 20 micrograme/24 ore

odyssea pharma sprl - belgia - levonorgestrelum - sist. cu cedare intrauterina - 20 micrograme/24 ore - contraceptive locale contraceptive locale

Yesafili Европейски съюз - румънски - EMA (European Medicines Agency)

yesafili

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologice - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.